A detailed history of Jane Street Group, LLC transactions in Icad Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 87,189 shares of ICAD stock, worth $343,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,189
Previous 87,189 -0.0%
Holding current value
$343,524
Previous $179,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$1.87 - $3.69 $163,043 - $321,727
87,189 New
87,189 $179,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $3.61 $57,150 - $114,617
31,750 New
31,750 $66,000
Q3 2020

Nov 17, 2020

SELL
$8.56 - $11.6 $165,627 - $224,448
-19,349 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$6.63 - $12.85 $34,190 - $66,267
-5,157 Reduced 21.04%
19,349 $193,000
Q1 2020

May 15, 2020

BUY
$6.94 - $14.42 $170,071 - $353,376
24,506 New
24,506 $179,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $99.8M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.